Contact Us

BUSINESS NEWS

$3M GRANT TO ACCELERATE DEVELOPMENT OF NEUROPLASTOGENS FOR SUBSTANCE USE DISORDER TREATMENT

Oct 29, 2024

CRC-P GRANT SECURED BY TESSARA THERAPEUTICS,PSYLO,AND THE UNIVERSITY OF SYDNEY TO ADVANCE BRAIN-REWIRING TREATMENTS FOR ADDICTION

Magical cultural magic from an ancient country in the East: “Black Myth: Wukong” is approved for sale in Taiwan

Oct 29, 2024

On Oct 11, Chinese AAA game “Black Myth: Wukong” was approved for sale in Taiwan after two months for sales.

RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation

Oct 28, 2024

PRINCETON,N.J.,Oct. 26,2024-- RiboX Therapeutics Ltd. (RiboX),a pioneering biopharmaceutical company,focused on discovering and developing fully engineered circular RNA therapeutics,announced that the

Connexion Shenzhen Return in December with Expanded Area and Upgradation, showcasing Catering/Hotel Supply/Furniture& Design/Health/Lifestyle/Packaging in one mega event

Oct 28, 2024

SHENZHEN,China,Oct. 28,2024-- Shenzhen,a young and vibrant city,is rapidly emerging as the "International Convention and Exhibition Capital". As one of the most open and economically dynamic

KIND Announces FDA Granted Orphan Drug Designation (ODD) for AND017 in the Treatment of Sickle Cell Disease (SCD)

Oct 28, 2024

SAN FRANCISCO,Oct. 26,2024-- Kind Pharmaceutical ("Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC"),a clinical-stage biopharmaceutical company focused on developing innovati

Update on 2024 Summer-Fall Exploration and Development Activities at Shaakichiuwaanaan, Quebec, Canada

Oct 28, 2024

VANCOUVER,BC,Oct. 28,2024-- October 28,2024 – Sydney,Australia Highlights 2024 drill campaign nearly complete having drilled ~127,700 m (428 holes) at Shaakichiuwaanaan since January.

1 ... 128 129 130 131 132 133 134 ... 234